ArticleBiomarker research2021

Co-expression of mesothelin and CA125/MUC16 is a prognostic factor for breast cancer, especially in luminal-type breast cancer patients.

Takahiro Einama et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.